glp 1 heart issues JCI JCI - Cardioprotective GLP-1 metabolite

The development of dual GIPRGLP1R coagonists that bind to either one or the other receptor (sequence-mixed dual agonists) has emerged as an innovative therapeutic strategy for obesity and type 2 diabetes

Your guide to understanding long-term GLP-1 use, weight maintenance, and what your body needs for sustainable results.

Background Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain

Understanding how telehealth prescribing works alongside genetic predispositions and clinical markers helps patients make informed decisions about suitability and medication choice

At least, some derivatives of berberine may

A component of the Gila monsters venoma peptide known as exendin-4is being explored for new treatments for Alzheimers disease, diabetes, and other diseases.